References

1. Leyden, Andrew P, Editor. Gulf War debriefing book: An after action report. Grants Pass, Oregon: Hellgate Press, 1997.

2. Murphy F, Browne D, Mather S, Scheele H, Hyams KC. Women in the Persian Gulf war: Implications for active duty troops and veterans. Mil Med 1997;162:656-660.

3. Duncan, Steven M. Citizen Warriors: America’s National Guard and Reserve Forces & the Politics of National Security. Novato, CA: Presidio Press, 1997.

4. Blanck RR, Bell WH. Special reports: medical aspects of the Persian Gulf war. N Engl J Med 1991;324:857-859.

5. Office of the Special Assistant for Gulf War Illnesses. Medical Surveillance During Operations Desert Shield/Desert Storm. November 6, 1997. /nfl.

6. Gunby P. Environment adds to challenges facing Desert Shield physicians. JAMA 1991;265:435,439,440.

7. Lindsay GC, Dasey C. Operations Desert Shield/Storm infectious disease rates: A fortuitous anomaly. United States Army Medical Research and Development Command News. February 1992:5-6.

8. Hyams KC, Hanson K, Wignall FS, Escamilla J, Oldfield EC. The impact of infectious diseases on the health of U.S. troops deployed to the Persian Gulf during Operations Desert Shield and Desert Storm. Clin Infect Dis 1995;20:1497-1504.

9. Writer JV, DeFraites RF, Brundage JF. Comparative mortality among US military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA 1996;275:118-121.

10. Miscellanea Medica. JAMA 1992;267:2579.

11. DeFraites RF, Wanat ER, Norwood AE, Williams S, Cowan D, Callahan T. Report, Investigation of a suspected outbreak of an unknown disease among veterans of Operation Desert Shield/Storm, 123d Army Reserve Command, Fort Benjamin Harrison, Indiana, April, 1992. Epidemiology Consultant Service (EPICON), Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, DC 20307; June 15, 1992.

12.Persian Gulf Veterans Coordinating Board. Unexplained illnesses among Desert Storm veterans: A search for causes, treatment, and cooperation. Arch Intern Med 1995;155:262- 268.

13.Beals P. Gulf illness. BMJ 1994;308:1574.

14. Revell T. The Gulf war syndrome. BMJ 1995;310:1073.

15. Coker WJ. A review of Gulf war illness. J R Nav Med Serv 1996;82:141-146.

16. Robinson A. Veterans worry that unexplained medical problems a legacy of service during Gulf War. Can Med Assoc J 1995;152:944-947.

17. Goss Gilroy Inc. Canadian Epidemiological Study of Gulf War Veterans. June, 1998.

18. Coker WJ, Bhatt BM, Blatchley NF, Graham JT. Clinical findings from the first 1000 Gulf war veterans in the Ministry of Defence's medical assessment programme. BMJ 1999:318:290-294.

19. Weber W. France investigates Gulf War syndrome. Lancet 2000;356:1747.

20. N� 3055, ASSEMBL�E NATIONALE, CONSTITUTION DU 4 OCTOBRE 1958 ONZI�ME L�GISLATURE, Enregistr� � la Pr�sidence de l'Assembl�e nationale le 15 mai 2001. RAPPORT D'INFORMATION D�POS�, en application de l'article 145 du R�glement PAR LA COMMISSION DE LA D�FENSE NATIONALE ET DES FORCES ARM�ES en conclusion des travaux d'une mission d'information sur les conditions d'engagement des militaires fran�ais ayant pu les exposer, au cours de la guerre du Golfe et des op�rations conduites ult�rieurement dans les Balkans, � des risques sanitaires sp�cifiques et pr�sent� par M. Bernard CAZENEUVE, Mme Mich�le RIVASI et M. Claude LANFRANCA, D�put�s. Found at DVS LLQIR-UDS IUQDW-DVVHPEOHHZZZ KWWS

21. Knoke JD, Gray GC, Garland FC. Testicular cancer and Persian Gulf war service. Epidemiology 1998;9:648-653.

22. Smith TC, Gray GC, Knoke JD. Is systemic lupus erythematosus, amyotrophic lateral sclerosis, or fibromyalgia associated with Persian Gulf War service? An examination of Department of Defense hospitalization. Am J Epidemiol 2000;151:1053-1059.

23. Charatan F. US links motor neurone disease with Gulf war service. BMJ 2002;324:65.

24. Penman AD, Currier MM, Tarver RS. No evidence of increase in birth defects and health problems among children born to Persian Gulf war veterans in Mississippi. Mil Med 1996;161:1-6.

25. Barkho L. Iraq blames U.S. for Gulf illnesses. Associated Press, December 2, 1998.

26. Employee Education System and Office of Public Health and Environmental Hazards, Department of Veterans Affairs. Veterans’ Health Initiative: A Guide to Gulf War Veterans' Health, June 2001. Continuing Medical Education Program, St. Louis VA Medical Center, March 2002. Found at http://www.va.gov/gulfwar/docs/VHIgulfwar.pdf.

27. Joseph SC, Hyams KC, Gackstetter GD, Mathews EC, Patterson RE. Persian Gulf War health issues. In: Rom WN, ed. Environmental and Occupational Medicine, 3rd edition. Lippincott-Raven Publishers, Philadelphia, August 1998.

28. Oldfield EC, Wallace MR, Hyams KC, Yousif AA, Bourgeois AL. Endemic infectious diseases of the Middle East. Rev Infect Dis 1991;13:s197-s217.

29. Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993;328:1383-1387.

30. Office of the Special Assistant for Gulf War Illnesses. Close-Out Report: Biological Warfare Investigation, Feb 22, 2001, /bw_ii.

31. The Research Working Group of the Persian Gulf Veterans Coordinating Board. Annual report to Congress: Federally sponsored research on Gulf war veterans' illnesses for 2001. Washington, DC: Department of Veterans Affairs, June 2002. Found at http://www.va.gov/resdev/prt/gulf_war_2001.

32. Committee on Veterans' Affairs, United States Senate. Report of the Special Investigation Unit on Gulf War illnesses. U.S. Government Printing Office, ISBN 0-16- 057362-9 (report) and ISBN 0-16-057367-X (appendices); 1998.

33. Special Oversight Board for Department of Defense Investigations of Gulf War Chemical and Biological Incidents. Final Report. December 2000, Washington, DC. http://www.oversight.ncr.gov.

34. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Al Jaber Air Base, Sept 25, 1997, /aljaber.

35. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Fox Detections in an ASP/Orchard, Sept 25, 1997, /asporchard.

36. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Kuwaiti Girls' School, Mar 19, 1998, /kuwaiti_school.

37. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Czech and French Reports of Possible Chemical Agent Detections, Aug 4, 1998, /czech_french.

38. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: 11th Marines, Nov 5, 1998, /11th_marines.

39. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Reported Detection of Chemical Agent Camp Monterey, Kuwait, Final Report, December 8, 1999, /camp_mont2.

40. Office of the Special Assistant for Gulf War Illnesses. Information Paper: The Use of Modeling and Simulation in the Planning of Attacks on Iraqi Chemical and Biological Warfare Targets, February 24, 2000, /aircampaign.

41. Office of the Special Assistant for Gulf War Illnesses. Close-Out Report: ARCENT Suspected Chemical Weapons Sites Investigation, Mar 14, 2000, /arcent.

42. Office of the Special Assistant for Gulf War Illnesses. Clo se-Out Report: Retrograde Equipment Investigation, March 21, 2000. Found at /retrograde_equipment.

43. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Tallil Air Base, Iraq, Final Report, May 22, 2000, /tallil_ii.

44. Office of the Special Assistant for Gulf War Illnesses. Close-Out Report: Possible Post-War Use of Chemical Warfare Agents Against Civilians by Iraq, May 25, 2000, /postwar.

45. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Possible Chemical Agent On Scud Missile Sample, Final Report, July 27, 2000, /scud_ii.

46. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: An Nasiriyah Southwest Ammunition Storage Point, Final Report, September 28, 2000, /an_iii.

47. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Fox Alerts in the 24th Infantry Division, Final Report, October 26, 2000, /fox_alerts_ii.

48. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Reported Mustard Exposure Operation Desert Storm, October 26, 2000, /fisher_ii.

49. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: US Demolition Operations at Khamisiyah, Dec 5, 2000, /khamisiyah_ii.

50. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Possible Chemical Warfare Agent Incident Involving a United States Marine, Final Report, Jan 25, 2001, /injured_marine_ii.

51. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: US Marine Corps Minefield Breaching, Final Report, Jan 31, 2001, /marine_b.

52. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Possible Mustard Release at Ukhaydir Ammunition Storage Depot, Final Report, Feb 16, 2001, /ukhaydir_ii.

53. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Al Jubayal, Saudi Arabia, Feb 22, 2001, http://www.gulflink.health.mil/al_jub_ii.

54. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: Chemical Warfare Agent Released at Muhammadiyat Ammunition Storage Site, Mar 27, 2001, /muhammadiyat.

55. Office of the Special Assistant for Gulf War Illnesses. Case Narrative: The Gulf War Air Campaign - Possible Chemical Warfare Agent Release at Al Muthanna, February 8, 1991; Mar 27, 2001, /al_muth.

56. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Al Jaber Air Base, Final Report, August 31, 2001, /al_jaber_ii.

57. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Fox Detections in an ASP/Orchard, Final Report, November 16, 2001, /asp_orch_ii/.

58. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Kuwaiti Girls' School, Final Report, September 13, 2001, /kuwaiti_final/.

59. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Final Report - 11th Marines, May 25, 2001, /11marines_ii/index.htm.

60. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Reported Mustard Exposure Operation Desert Storm, Final Report, July 12, 2001, /fisher_final.

61. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: US Demolition Operations at Khamisiyah, Final Report, April 25, 2002, /khamisiyah_iii.

62. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Modeling and Risk Characterization of US Demolitions at the Khamisiyah Pit (Technical Report), April 25, 2002, htp://www.gulflink.health.mil/khamisiyah_tech.

63. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Al Jubayal, Saudi Arabia, Final Report, October 25, 2001, /al_jub_iii.

64. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Chemical Warfare Agent Released at Muhammadiyat Ammunition Storage Site, Final Report, April 4, 2002, /muhammadiyat_ii.

65. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: The Gulf War Air Campaign - Possible Chemical Warfare Agent Release at Al Muthanna, Final Report, November 15, 2001, /al_muth_ii.

66. Special Assistant for Gulf War Illnesses, Medical Readiness, and Military Deployments. Case Narrative: Reported Chemical Warfare Agent Exposure in the 2d Reconnaissance Battalion, Final Report, November 15, 2001, /2d_recon_i.

67. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Inhibited Red Fuming Nitric Acid (IRFNA), August 3, 1999, /irfna.

68. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Iraq's Scud Ballistic Missiles, February 12, 2001, /scud_info_ii.

69. Office of the Special Assistant for Gulf War Illnesses. Information Paper: M256 Series Chemical Agent Detector Kit, July 23, 1999, /m256.

70. Office of the Special Assistant for Gulf War Illnesses. Information Paper: M8A1 Automatic Chemical Agent Alarm, October 30, 1997, /m8a1alarms.

71. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Military Medical Recordkeeping During and After the War, August 11, 1999, /mrk.

72. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Medical Surveillance During Operations Desert Shield/Desert Storm, November 6, 1997, /nfl.

73. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Mission Oriented Protective Posture (MOPP) and Chemical Protection, October 30, 1997, /mopp.

74. Office of the Special Assistant for Gulf War Illnesses. Information Paper: Vaccine Use During the Gulf War, December 7, 2000, /va.

75. Office of the Special Assistant for Gulf War Illnesses. Close-out Report: Biological Warfare Investigation, February 13, 2001, /bw_ii/fig1.htm.

76. Office of the Special Assistant for Gulf War Illnesses. Close-out Report: Water Use, February 24, 2000, /water_use.

77. Jamal GA, Hansen S, Apartopoulos F, Peden A. The "Gulf War syndrome." Is there evidence of dysfunction in the nervous system? J Neurol Neurosurg Psychiatry 1996;60:449-451

78. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemical exposures. J Toxicol Environ Health 1996;48:35-56.

79. Haley RW, Kurt TL, Horn J: Is there a Gulf war syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997;277:215-222.

80. Haley RW, Horn J, Roland PS, Bryan WW, Van Ness PC, Bonte FJ, Devous MD Sr, Mathews D, Fleckenstein JL, Wians FH Jr, Wolfe GI, Kurt TL. Evaluation of neurologic function in Gulf war veterans: A blinded case-control study. JAMA 1997;277:223-230.

81. Haley RW, Kurt TL. Self-reported exposure to neurotoxic chemical combinations in the Gulf war: A cross-sectional epidemiologic study. JAMA 1997;277:231-237.

82. Loewenstein-Lichtenstein Y, Schwarz M, Glick D, Norgaard-Pedersen B, Zakut H, Soreq H. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nat Med 1995;1:1082-5.

83. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 10th Edition. Hardman JG, Limbird LE, eds. New York: The McGraw-Hill Companies, Inc., 2001.

84. United States Army. Final Report: Kuwait oil fire health risk assessment, No. 39.26-L192-91, 5 May - 3 December 1991. Department of the Army, U.S. Army Environmental Hygiene Agency, Aberdeen Proving Ground, MD; 1994.

85. Office of the Special Assistant for Gulf War Illnesses. Oil well fire contaminants below hazardous levels. Nove mber 10, 1998. Found at /news/na_oilwell_9nov98.html.

86. Petruccelli BP, Goldenbaum M, Scott B, Lachiver R, Kanjarpane D, Elliott E, Francis M, McDiarmid MA, Deeter D. Health Effects of the 1991 Kuwait Oil Fires: A survey of US Army Troops. JOEM 1999;41:433-439.

87. White CS, Adler WH, McGann VG. Repeated immunization: possible adverse effects. Reevaluation of human subjects at 25 years. Ann Intern Med 1974;81:594-600.

88. Hotopf M, David A, Hull L, Ismail K, Unwin C, Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. BMJ 2000;320:1363-1367.

89. Shaheen S. Shots in the desert and Gulf war syndrome. Evidence that multiple vaccinations during deployment are to blame is inconclusive. BMJ 2000;320:1351-1352.

90. Cherry N, Creed F, Silman A, Dunn G, Baxter D, Smedley J, Taylor S, Macfarlane GJ. Health and exposures of United Kingdom Gulf War veterans. Part II: The relation of health to exposure. Occup Environ Med 2001;58:299-306.

91. Steele L. Prevalence and patterns of Gulf War illness in Kansas veterans: Association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 2000;152:992-1002.

92. Hart MK, Del Giudice RA, Korch GW Jr. Absence of mycoplasma contamination in the anthrax vaccine. Emerg Infect Dis 2002;8:94-96.

93. Institute of Medicine, Medical Follow-up Agency. The Anthrax Vaccine: Is it Safe? Does it Work? Washington, D.C.: National Academy Press; 2002.

94. McDiarmid MA, Engelhardt SM, Oliver M. Urinary uranium concentrations in an enlarged Gulf War veteran cohort. Health Phys 2001;80:270-273.

95. McDiarmid MA. Depleted uranium and public health. BMJ 2001;322:123-124.

96. McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R, Kabat M, Kaup B, Anderson L, Hoover D, Brown L, Jacobson-Kram D; Depleted Uranium Follow-Up Program. Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort. J Occup Environ Med 2001;43:991- 1000.

97. Office of the Special Assistant for Gulf War Illnesses. Depleted uranium environmental exposure report released. August 4, 1998. Found at /news/na_du_080498.html.

98. Grinker RR, Spiegel JP. The syndrome of "Operational Fatigue" (War Neuroses) in returnees. In: Men Under Stress. York, PA: Maple Press Company, 1945:208-224.

99. Bremner JD, Scott TM, Delaney RC, Southwick SM, Mason JW, Johnson DR, Innis RB, McCarthy G, Charney DS. Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry 1993;150:1015-1019.

100. Sutker PB, Uddo M, Brailey K, Allain AN. War-zone trauma and stress-related symptoms in Operation Desert Shield/Storm (ODS) returnees. J Soc Issues 1993;49:33-49.

101. Sutker PB, Uddo M, Brailey K, Allain AN, Errera P. Psychological symptoms and psychiatric diagnoses in Operation Desert Storm troops serving graves registration duty. J Trauma Stress 1994;7:159-171.

102. Sutker PB, Davis JM, Uddo M, Ditta SR. Assessment of psychological distress in Persian Gulf troops: Ethnicity and gender comparisons. J Pers Assess 1995;64:415-27.

103. Stretch RH, Wright KM, Bliese PD, Knudson KH, Marlowe DH, Hoover CH. Physical health symptomatology of Gulf War-era service personnel from the states of Pennsylvania and Hawaii. Mil Med 1995;160:131-136.

104. Ford JD, Campbell KA, Storzbach D, Binder LM, Anger WK, Rohlman DS. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med 2001;63:842-849.

105. Korenyi-Both AL, Korenyi-Both AL, Molnar AC, Fidelus-Gort R. Al Eskan disease: Desert Storm pneumonitis. Mil Med 1992;157:452-462.

106. Korenyi-Both AL, Korenyi- Both AL, Juncer DJ. Al Eskan disease: Persian Gulf syndrome. Mil Med 1997;162:1-13.

107. Korenyi-Both AL, Laszlo S, Korenyi-Both GE, Juncer DJ, Korenyi-Both AL, Akos S. The role of the sand in chemical warfare agent exposure among Persian Gulf war veterans: Al Eskan Disease and "Dirty Dust." Mil Med 2000;165:321-336.

108. Richards AL, Hyams KC, Watts DM, Rozmajzl PJ, Woody JN, Merrell BR. Respiratory disease among military personnel in Saudi Arabia during Operation Desert Shield. Am J Pub Health 1993;83:1326-1329.

109. Hollander DH. Beef allergy and the Persian Gulf syndrome. Medical Hypotheses 1995;45:221-222.

110. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigime brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med 1996;2:1382-1385.

111. Lallement G, Foquin A, Baubichon D, Burckhart MF, Carpentier P, Canini F. Heat Stress, even extreme, does not induce penetration of pyridostimine into the brain of guinea pigs. Neurotoxicology 1998;19:759-766.

112. Telang FW, Ding Y-S, Volkow ND, Molina PE, Gatley SJ. Nucl Med Biol 1999;26:249- 250.

113. Grauer E, Alkalai D, Kapon J, Cohen G, Raveh L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol Appl Pharmacol 2000;164:301-304.

114. Sinton CM, Fitch TE, Petty F, Haley RW. Stressful manipulations that elevate corticosterone reduce blood-brain permeability to pyridostigmine in the rat. Toxicol Appl Pharmacol 2000;165:99-105.

115. Hyams KC, Wignall FS, Roswell R. War syndromes and their evaluatio n: From the U.S. Civil War to the Persian Gulf War: Ann Intern Med 1996;125:398-405.

116. Parliamentary Office of Science and Technology. Gulf war illnesses: Dealing with the Uncertainties. ISBN 1 897941 66 8; December 1997

117. The Iowa Persian Gulf Study Group. Self-reported illness and health status among Gulf war veterans. JAMA 1996;277:238-245.

118. Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, Noah DL, Barrett DH, Randall B, Herwaldt BL, Mawle AC, Reeves WC. Chronic multisymptom illness affecting Air Force veterans of the Gulf war. JAMA 1998;280:981-988.

119. Unwin C, Blatchley N, Coker W, Ferry S, Hotopf M, Hull L, Ismail K, Palmer I, David A, Wessely S.. The health of United Kingdom servicemen who served in the Persian Gulf war. Lancet 1999;353:169-178.

120. Cherry N, Creed F, Silman A, Dunn G, Baxter D, Smedley J, Taylor S, Macfarlane GJ. Health and exposures of United Kingdom Gulf war veterans. Part I: The pattern and extent of ill health. Occup Environ Med 2001;58:291-298.

121. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM. Illnesses among United States Veterans of the Gulf War: A population-based survey of 30,000 veterans. JOEM 2000;42:1-11.

122. Kang H, Magee C, Mahan C, Lee K, Murphy F, Jackson L, Matanoski G. Pregnancy outcomes among U.S. Gulf War veterans. A population-based survey of 30,000 veterans. Ann Epidemiol 2001;11:504-511.

123. Gray GC, Coate BD, Anderson CM, Kang HK, Berg SW, Wignall FS, Knoke JD, Barrett-Connor E. The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med 1996;335:1505-1513.

124. Gray GC, Smith TC, Kang HK, Knoke JD. Are Gulf War veterans suffering war-related illnesses? Federal and civilian hospitalizations examined, June 1991 to December 1994. Am J Epidemiol 2000;151:63-71.

125. Knoke JD, Gray GC. Hospitalizations for unexplained illnesses among U.S. veterans of the Persian Gulf War. Emerg Infect Dis 1998;4:211-219.

126. Cowan DN, DeFraites RF, Gray GC, Goldenbaum MB, Wishik SM. A records-based evaluation of the risk of birth defects among children of Gulf war veterans. N Engl J Med 1997;336:1650-1656.

127. Araneta MR, Destiche DA, Schlangen KM, Merz RD, Forrester MB, Gray GC. Birth defects prevalence among infants of Persian Gulf War veterans born in Hawaii, 1989-1993. Teratology 2000;62:195-204.

128. Kang HK, Bullman TA. Mortality among U.S. veterans of the Persian Gulf War. N Engl JMed 1996;335:1498-1504.

129. Kang HK, Bullman TA. Mortality among US veterans of the Persian Gulf War: 7- year follow-up. Am J Epidemiol 2001;154:399-405.

130. Dlugosz LJ, Hocter WJ, Kaiser KS, Knoke JD, Heller JM, Hamid NA, Reed RJ, Kendler KS, Gray GC. Risk factors for mental disorder hospitalization after the Persian Gulf War: U.S. Armed Forces, June 1, 1991-September 30, 1993. J Clin Epidemiol 1999; 52:1267- 1278.

131. Gray GC, Kaiser KS, Hawksworth AW, Hall FW, Barrett-Connor E. Increased postwar symptoms and psychological morbidity among U.S. Navy Gulf War veterans. Am J Trop Med Hyg 1999; 60:758-766.

132. Department of Defense. Report of the Defense Science Board Task Force on Persian Gulf War Health Effects, June 1994. Washington, D.C.: Office of the Under Secretary of Defense for Acquisition and Technology; 1994.

133. National Institutes of Health Technology Assessment Workshop Panel. The Persian Gulf Experience and Health. JAMA 1994;272:391-395.

134. Institute of Medicine. Health consequences of service during the Persian Gulf war: Recommendations for research and information systems. Washington, D.C.: National Academy Press; 1996.

135. Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. Evaluation of the U.S. Department of Defense Persian Gulf Comprehensive Clinical Evaluation Program. Washington, D.C.: National Academy Press; 1995.

136. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Interim Report. Washington, D.C., U.S. Government Printing Office, February 1996, ISBN 0-16-048520-7.

137. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Final Report. Washington, D.C., U.S. Government Printing Office, December 1996, ISBN 0-16-048942- 3.

138. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Special Report. Washington, D.C., U.S. Government Printing Office, October 1997, ISBN 0-16-049285-8.

139. Joellenbeck LM, Hernandez LM. The Institute of Medicine’s independent scientific assessment of Gulf War health issues. Mil Med 2002;167:186-190.

140. Institute of Medicine, September 2000. Carolyn E. Fulco, Catharyn T. Liverman, Harold C. Sox, eds, Committee on Health Effects Associated with Exposures During the Gulf War. Gulf War and health: Volume 1. Depleted uranium, sarin, pyridostigmine bromide, vaccines. Washington, D.C.: National Academy Press.

141. Institute of Medicine. Press release: Gulf War and health: Volume 1. Depleted uranium, sarin, pyridostigmine bromide, vaccines. Sept 7, 2000, Washington, DC.

142. Committee on Strategies to Protect the Health of Deployed U.S. Forces, Institute of Medicine. Protecting those who served: Strategies to protect the health of deployed U.S. Forces. Washington, DC: National Academy Press, 2000. page 11

143. Anonymous. "Balkan war syndrome." Lancet 2000; 355:1250.

144. Marusic A, Ramsay S. NATO doctors question "Balkan war syndrome." Lancet 2001;357:201.

145. Soetekouw PM, de Vries M, van Bergen L, Galama JM, Keyser A, Bleijenberg G, van der Meer JW. Somatic hypotheses of war syndromes. Eur J Clin Invest 2000;30:630-641.

146. Williams, Daniel. Russian troops face ‘Chechnya Syndrome.’ Washington Post, August 6, 2000, page A20.

147. Kaminski, Matthew. Dutch government decides to treat battlefield as hazardous workplace. Wall Street Journal. April 17, 2001.

148. Murphy FM, Kang H, Dalager NA, Lee KY, Allen RE, Mather SH, Kizer KW. The health status of Gulf War veterans: Lessons learned from the Department of Veterans Affairs Health Registry. Mil Med 1999;164:327-331.

149. The International Classification of Diseases-Ninth Revision, Clinical Modification (ICD-9- CM). Commission on Professional and Hospital Activities, Ann Arbor, Michigan; 1986.

150. Schmitt, Eric. Military to start intensive testing of ailing Gulf War veterans. New The York Times, May 12, 1994, page 18.

151. Institute of Medicine. Adequacy of the Comprehensive Clinical Evaluation Program: A Focused Assessment. Washington, D.C.: National Academy Press; 1997.

152. Institute of Medicine. Adequacy of the Comprehensive Clinical Evaluation Program: Nerve Agents. Washington, D.C.: National Academy Press; 1997.

153. Institute of Medicine. Adequacy of the VA Persian Gulf Registry and Uniform Case Assessment Protocol. Washington, D.C.: National Academy Press; 1998.

154. Roy MJ, Chung RCY, Huntley DE, Blanck RR. Evaluating the symptoms of Persian Gulf War veterans. Federal Practitioner 1994;11:13-16, 22.

155. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSMIII- R--Non-Patient Edition (SCID-NP, Version 1.0). American Psychiatric Press, Washington, DC; 1990.

156. Blake D, Weathers F, Nagy L. Clinician-Administered PTSD Scale (CAPS). National Center for Posttraumatic Stress Disorder, Behavioral Science Division, VAMC, Boston, MA; 1990.

157. Department of Defense Report. Clinical Evaluation Program for Gulf War Veterans: Preliminary Status Report on the First 1000 Patients. Washington, DC; December 1994.

158. Department of Defense Report. Comprehens ive Clinical Evaluation Program (CCEP) for Gulf War Veterans: Report on 10,020 Participants. Washington, DC; August 1995.

159. Department of Defense Report. Comprehensive Clinical Evaluation Program for Persian Gulf War Veterans: CCEP Report on 18,598 Participants. Washington, DC; April 2, 1996.

160. Joseph SC, and the Comprehensive Clinical Evaluation Program Evaluation Team. A comprehensive clinical evaluation of 20,000 Gulf War veterans. Mil Med 1997;1997;162:149-155.

161. Roy MJ, Koslowe PA, Kroenke K, Macgruder C. Signs, symptoms, and ill-defined conditions in Persian Gulf war veterans: Findings from the comprehensive clinical evaluation program. Psychosomatic Med 1998;60:663-668.

162. Engel CC, Kayanan D, Roy M, Ursano R. Multidisciplinary treatment of persistent symptoms after Gulf war service. Mil Med 1998;163:202-208.

163. Engel CC, Liu X, Clymer R, Miller RF, Sjoberg T, Shapiro JR. Rehabilitative care of warrelated health concerns. JOEM 2000;42:385-390.

164. Chesbrough KB, Ryan MAK, Amoroso P, Boyko EJ, Gackstetter GD, Hooper TI, Riddle JR, Gray GC, and the Millennium Cohort Study Group. The Millennium Cohort Study: a 21-year prospective cohort study of 140,000 military personnel. Mil Med 2002;167:483-488.

165. Murphy FM. Gulf war syndrome. BMJ 1999;318:274-275.

166. Lee HA, Gabriel R, Bale AJ, Bolton P, Blatchley NF. Clinical findings of the second 1000 UK Gulf War veterans who attended the Ministry of Defence’s Medical Assessment Programme. J R Army Med Corps 2001;147:153-160.

167. Hull L, David AS, Hyams KC, Unwin C, Wessely SC, Hotopf M. Self- reported health of Gulf War veterans: A comparison of help-seeking and randomly ascertained cases. In press, Mil Med 2002.

168. Gray GC, Hawksworth AW, Smith TC, Kang HK, Knoke JD, Gackstetter GD. Gulf war veterans' health registries: Who is most likely to seek evaluation? Am J Epidemiol 1998;148:343-349.

169. Solomon Z, Waysman M, Levy G, Fried B, Mikulincer M, Benbenishty R, Florian V, Bleich A. From front line to home front: A study of secondary traumatization. Fam Process 1992;31:289-302.

170. Voelker MD, Saag KG, Schwartz DA, Chrischilles E, Clarke WR, Woolson RF, Doebbeling BN. Health-related quality of life in Gulf War era military personnel. Am J Epidemiol 2002; 155:899-907.

171. Hyams KC, Riddle R, Trump D, Graham JT. Endemic infectious diseases and biological warfare during the Gulf War: A decade of analysis and final concerns. Am J Trop Med Hyg 2001;65:664-670.

172. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 558.

173. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 617.

174. Everson MP, Shi K, Aldridge P, Bartolucci AA, Blackburn WD. Immunological responses are not abnormal in symptomatic Gulf War veterans. Ann NY Acad Sci 2002;966:327-342.

175. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 2111.

176. Mokdad, AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200.

177. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790- 797.

178. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, pages 368, 369.

179. Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ. One- month prevalence of mental disorders in the United States: Based on five epidemiologic catchment area sites. Arch Gen Psychiatry 1988;45:977-986.

180. Ismail K, Davies K, Brugha T, David A, Hotopf M, Hull L, Palmer I, Reid S, Unwin C, Wessely S. Do psychiatric disorders explain ill health in United Kingdom Gulf veterans? In Press, BMJ 2002.

181. Haley RW, Billecke S, LaDu BN. Association of low PON1 Type Q (Type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 1999;157:227-233.

182. Mackness B, Durrington PN, Mackness MI. Low paraoxonase in Persian Gulf War veterans self-reporting Gulf War syndrome. Biochemical and Biophysical Research Communications 2000;276:729-733.

183. Horn J, Haley RW, Kurt TL. Neuropsychological correlates of Gulf War syndrome. Arch Clin Neurophychology 1997;12:531-544.

184. Haley RW, Marshall WW, McKonald GG, Daugherty MA, Petty F, Fleckenstein JL. Brain abnormalities in Gulf War syndrome: evaluation with 1H MR spectroscopy. Radiology 2000;215:807-817.

185. Haley RW, Fleckenstein JL, Marshall WW, McDonald GG, Kramer GL, Petty F. Effect of basal ganglia injury on central dopamine activity in Gulf War syndrome: correlation of proton magnetic resonance spectroscopy and plasma homovanillic acid levels. Arch Neurol 2000;57:1280-1285.

186. Roland PS, Haley RW, Yellin W, Owens K, Shoup AG. Vestibular dysfunction in Gulf War syndrome. Otolaryngol Head Neck Surg 2000;122:319-329.

187. Haley RW, Maddrey AM, Gershenfeld HK. Severely reduced functional status in veterans fitting a case definition of Gulf War syndrome. Am J Public Health 2002;92:46-47.

188. Newmark J, Clayton WL. Persian Gulf illnesses: preliminary neurological impressions. Mil Med 1995;160:505-507.

189. Goldstein G, Beers SR, Morrow LA, et al. A preliminary neuropsychological study of Persian Gulf veterans. J Int Neuropsychol Soc 1996;2:368-371.

190. Sillanpaa MC, Agar LM, Milner IB, Podany EC, Axelrod BN, Brown GG. Gulf War veterans: a neuropsychological examination. J Clin Exp Neuropsychol 1997;19:211-219.

191. Axelrod BN, Milner IB. Neuropsychological findings in a sample of Operation Desert Storm veterans. J Neuropsychiatry 1997;9:23-28.

192. Amato AA, McVey A, Cha C, Matthews EC, Jackson CE, Kleingunther R, Worley L, Cornman E, Kagan-Hallet K. Evaluation of neuromuscular symptoms in veterans of the Persian Gulf War. Neurology 1997;48:4-12.

193. Rivera-Zayas J, Arroyo M, Mejias E. Evaluation of Persian Gulf veterans with symptoms of peripheral neuropathy. Mil Med 2001;166:449-451.

194. Kaiser KS, Hawksworth AW, Gray GC. Pyridostigmine bromide intake during the Persian Gulf war is not associated with postwar handgrip strength. Mil Med 2000;165:165-168.

195. Spencer PS, McCauley LA, Lapidus JA, Lasarev M, Joos SK, Storzbach D. Self- reported exposures and their association with unexplained illness in a population-based case-control study of Gulf War veterans. J Occup Environ Med 2001;43:1041-1056.

196. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 1414.

197. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 1456.

198. Smith TC, Heller JM, Hooper TI, Gackstetter GD, Gray GC. Are Gulf War veterans experiencing illness due to exposure to smoke from Kuwaiti oil well fires? Examination of Department of Defense hospitalization data. Am J Epidemiol 2002;155:908-917.

199. Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med 2001;344:1846-1850.

200. Krivda SJ, Roy MJ, Chung RCY, James WD. Cutaneous findings in Gulf War veterans. Arch Dermatol 1996;132:846-847.

201. Pehr K, Kornfeld BW. Dermatology in a war zone: A Persian Gulf experience. Int J Derm 1992;31:494-497.

202. Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Public Health 1984;74:574-579.

203. Harrison’s Principles of Internal Medicine, 15th Edition. Braunwald E, Hauser SL, Fauci AS, Longo DL, Kasper DL, Jameson JL, eds. New York: McGraw-Hill Medical Publishing Division, 2001, page 1979.

204. Truax AL, Chandnani VP, Chacko AK, Gonzalez DM. Incidence and methods of diagnosis of musculoskeletal injuries incurred in Operations Desert Shield and Desert Storm. Invest Radiol 1997;32:169-173.

205. West SG. Rheumatic disorders during Operation Desert Storm. Arthritis Rheumatism 1993;36:1487.

206. Escalante A, Fischbach M. Musculoskeletal manifestations, pain, and quality of life in Persian Gulf War veterans referred for rheumatologic evaluation. J Rheumatol. 1998;25:2228-2235.

207. Grady EP, Carpenter MT, Koenig CD, Older SA, Battafarano DF. Rheumatic findings in Gulf War veterans. Arch Intern Med. 1998;158:367-371.

208. Erickson AR, Enzenauer RJ, Bray VJ, West SG. Musculoskeletal complaints in Persian Gulf War veterans. J Clin Rheumatol 1998;4:181-185.

209. Bourdette DN, McCauley LA, Barkhuizen A, Johnston W, Wynn M, Joos SK, Storzbach D, Shuell T, Sticker D. Symptom factor analysis, clinical findings, and functional status in a population-based case control study of Gulf War unexplained illness. J Occup Environ Med 2001;43:1026-1040

210. Kroenke K, Mangelsdorff AD. Common symptoms in amb ulatory care: Incidence, evaluation, therapy, and outcome. Am J Med 1989;86:262–266.

211. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990;150:1685–1689.

212. Kroenke K, Spitzer RL, Williams JBW, Linzer M, Hahn SR, deGruy FV, Brody D. Physical symptoms in primary care: Predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774–779.

213. Schappert SM. National Ambulatory Medical Care Survey: 1989 summary. Vital Health Stat [13] 1992;110:2-11.

214. Marple RL, Kroenke K, Lucey CR, Wilder J, Lucas CA. Concerns and expectations in patients presenting with physical complaints: frequency, physician perceptions and actions, and 2-week outcome. Arch Intern Med 1997;157:1482-1488.

215. Jones E, Hodgins-Vermaas R, McCartney H, Everitt B, Beech C, Poynter D, Palmer I, Hyams K, Wessely S. Post-combat syndromes from the Boer war to the Gulf war: a cluster analysis of their nature and attribution. BMJ 2002;324:321-324.

216. Katon W, Egan K, Miller D. Chronic pain: Lifetime psychiatric diagnoses and family history. Am J Psych 1985;142:1156–1160.

217. Katon WJ, Buchwald DS, Simon GE, Russo JE. Psychiatric illness in patients with chronic fatigue and those with rheumatoid rrthritis. J Gen Intern Med 1981;6:277–285.

218. Goldenberg DL. Fibromyalgia syndrome: An emerging but controversial condition. JAMA 1987;257:2782–2787.

219. Black DW, Rathe A, Goldstein RB. Environmental illness: A controlled study of 26 subjects with "20th Century Disease." JAMA 1990;264:3166–3170.

220. Simon GE, Katon WJ, Sparks PJ. Allergic to life: Psychological factors in environmental illness. Am J Psychiatry 1990;147:901–906.

221. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363–367.

222. Kisely SR, Goldberg DP. The effect of physical ill health on the course of psychiatric disorder in general practice. Br J Psychiatry 1997;170:536-540.

223. Katon W, Russo J. Chronic fatigue syndrome criteria. A critique of the requirement for multiple physical complaints. Arch Intern Med 1992;152:1604–1609.

224. Russo J, Katon W, Sullivan M, Buchwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics 1994;35:546–556.

225. Kisely S, Goldberg D, Simon G. A Comparison between somatic symptoms with and without clear organic cause: Results of an international study. Psychol Med 1997;27:1011– 1019.

226. Dworkin SF, Von Korff M, LeResche L. Multiple pains and psychiatric disturbance: An epidemiologic investigation. Arch Gen Psychiatry 1990;47: 239–244.

227. Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH epidemiologic catchment area study. Am J Psychiatry 1991;148:1494–500.

228. Katon W, Lin E, Von Korff M, Russo J, Lipscomb P, Bush T. Somatization: A Spectrum of severity. Am J Psychiatry 1991;148:34–40.

229. Sullivan MD, Katon W, Dobie R, Sakai C, Russo J, Harrop-Griffiths J. Disabling tinnitus: Association with affective disorder. Gen Hosp Psychiatry 1988;10:285–291.

230. Walker E, Katon W, Harrop-Griffiths J, Holm L, Russo J, Hickok LR. Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry 1988;145:75–80.

231. Walker EA, Roy-Byrne PP, Katon WJ, Li L, Amos D, Jiranek G. Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease. Am J Psychiatry 1990;147:1656–1661.

232. Leino P, Magni G. Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: A 10-year follow-up of metal industry employees. Pain 1993;53:89–94.

233. Von Korff M, LeResche L, Dworkin SF. First onset of common pain symptoms: A prospective study of depression as a risk factor. Pain 1993;55:251–258.

234. Kroenke K, Koslowe P, Roy M. Symptoms in 18,495 Persian Gulf War veterans. JOEM 1998;40:520-528.

235. Baker DG, McQuarrie IG, Murray MG, Lund LM, Dashevsky BA, Mendenhall CL. Diagnostic status and treatment recommendations for Persian Gulf War Veterans with multiple nonspecific symptoms. Mil Med 2001;166:972-981.

236. Natelson BH, Tiersky L, Nelson J. The diagnosis of posttraumatic stress disorder in Gulf veterans with medically unexplained fatiguing illness. J Nerv Ment Dis 2001;189:795-796.

237. Joellenbeck LM, Landrigan PJ, Larson EL. Gulf war veterans' illnesses: A case study in causal inference. Environmental Research 1998;79:71-81.

238. Spencer PS, McCauley LA, Joos SK, Lasarev MR, Schuell T, Bourdette D, Barkhuizen A, Johnston W, Storzbach D, Wynn M, Grewenow R. U.S. Gulf War veterans: Service periods in theater, differential exposures, and persistent unexplained illness. Toxicology letters 1998;102-103:515-521.

239. Gray GC, Smith TC, Knoke JD, Heller JM. The postwar hospitalization experience of Gulf War veterans possibly exposed to chemical munitions destruction at Khamisiyah, Iraq. Am J Epidemiol 1999; 150:532-540.

240. Kang HK, Bullman T. Mortality among U.S. Gulf veterans who were potentially exposed to nerve gas at Khamisiyah, Iraq. Environmental Epidemiology Service, Veterans, Health Administration, Washington, DC; April 25, 2002.

241. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med 2001;134:330-334.

242. Speckens AEM, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HGM. Cognitive behavioural therapy for medically unexplained physical symptoms: a randomized controlled trial. BMJ 1995;311:1328-1332.

243. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JWM. Cognitive behavious therapy for chronic fatigue syndrome: a multicentre randomized controlled trial. Lancet 2001;357:841-847.

244. Brown MA, Murphy FM, Mather SH. Innovation in veterans’ health care and assistance: The Department of Veterans Affairs 10 years after the Gulf War. Mil Med 2002;167:191- 195.

245. Trump DH, Mazzuchi JF, Riddle J, Hyams KC, Balough B. Force health protection: 10 years of lessons learned by the Department of Defense. Mil Med 2002;167:179-185.

246. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, Medical Readiness and Military Deployments. The future of post-deployment health care. September 7, 2001 - WASHINGTON (DeploymentLINK). Found at http://www.deploymentlink.osd.mil/news/sep01/news_90701_001.shtml.

247. Department of Defense. DeploymentLINK: Deployment Health Support. Found at http://www.deploymentlink.osd.mil.

248. Department of Defense, PDHealth.mil. DoD Post-Deployment Health, Washington, DC. Found at http://www.pdhealth.mil.

 

| First Page | Prev Page | Next Page |